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would be an increased concentration of the interacting drug (in
50% of hospitalizations), in 10% a serious toxicity could occur
due to the DDI (QTc prolongation, rhabdomyolysis). CON-
CLUSIONS: We showed that the potential for moderate and
severe drug-drug interactions is prominent in hospitalized
persons who are treated with triazoles. These DDI’s may impact
on the outcomes of this patient population.
INFECTION (including HIV, CAP)
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OBJECTIVES: To compare dynamic with static modeling for the
economic evaluation of screening programs for asymptomatic
genital Chlamydia trachomatis infections in sexually active
women. METHODS: We compared a stochastic network simu-
lation model (dynamic model) and a decision analysis model
(static model) for estimating the cost-effectiveness of an oppor-
tunistic general practitioner-based screening program for the ﬁrst
10 years of screening in The Netherlands. The inﬂuence of the
model type on the requested data, the computed results and the
sensitivity of model parameters were investigated. RESULTS:
The dynamic model yielded diverging outcomes and identiﬁed
different optimal screening strategies than the static model:
Screening women aged 15–24 years results in net savings
(dynamic model) or net costs (static model). Screening women
aged 15–29 years or 15–34 years dominates (dynamic model) or
is less cost-effective (static model) than screening women aged
15–24 years. These differences are caused by the fact that unlike
the static model the dynamic model is able to consider popula-
tion effects, i.e. changes in the force of infection (per-susceptible
rate of infection) caused by screening. However, it is more
complex and requires more data and time and thus is more costly
than the static model. It is also more sensitive to parameter
changes that affect the force of infection (e.g. partner referral
rate). CONCLUSIONS: Dynamic models should be applied for
the economic evaluation of prevention measures that have the
potential to lower the force of infection in a population, such as
large-scale screening programs for Chlamydia trachomatis.
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OBJECTIVES: Uncertainty in the estimation of the incremental
cost-effectiveness ratio (ICER) is usually described by bootstrap
conﬁdence intervals. When bootstrap replicates cover more than
one quadrant of the cost-effectiveness plane angular transfor-
mation of the ICER is appropriate. In a simulation study the per-
formance of the most common bootstrap methods (normal,
percentile, bias corrected with and without acceleration correc-
tion) is investigated. METHODS: Cost data were generated
according to a lognormal distribution, effect data were drawn
from normal distributions. The simulation frame work covers
180 settings differing in correlation between costs and beneﬁts
(0.9, 0.45, 0, 0.45, 0.9), in standardized mean difference of
beneﬁt and cost (each 0.2, 1, 5) and in sample size (50, 100, 200,
400). For each setting 10,000 samples were generated. The boot-
strap procedures were based on 1000 replications. The perfor-
mance of each procedure was described by the observed coverage
probability of the 95%-conﬁdence intervals. RESULTS: Overall,
the percentile method demonstrates the highest robustness with
miscoverage frequencies between 4% and 7%. The bias cor-
rected methods performs also well in terms of miscoverage, but
tend to show wider conﬁdence intervals compared to the per-
centile method. The normal approach shows the smallest ranges
given small effect differences. However in conjunction with small
cost differences and in case of negatively correlated data up to
15% miscoverage is observed and a strong conservative behav-
iour is found in case of positive correlation. CONCLUSIONS:
The more sophisticated methods result in wider conﬁdence inter-
vals compared to the normal and percentile approach. Recently
developed methods as bootstrapping the bootstrap or (weighted)
jacknife after bootstrap, which do not depend on parametric
assumptions in accounting for median bias, may present a
promising alternative. However, in order to avoid computation-
ally intensive procedures the bootstrap percentile method is gen-
erally recommended.
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Uncertainty—The lack of perfect knowledge of the parameter
value—and variability—heterogeneity of the population that is
a consequence of the physical system and irreducible by addi-
tional measurements—are usually presented together as sources
of variation of the model parameters in the economic evaluation
(henceforth EE) of health care programs. OBJECTIVES: In this
presentation, we illustrate how second-order models may be
highly relevant for EE and we show that separation of uncer-
tainty and variability is not only necessary to estimate bounds of
risk but may also quantitatively affect the outcome of the EE.
METHODS: An application to the analysis of cost data is pro-
vided by using three different methods. First, we make a 
deterministic estimate, without using probability distributions.
Secondly, we derive probability distributions for the model para-
meters without separating uncertainty and variability. Thirdly,
we do the same with making this distinction. RESULTS: The sep-
aration of uncertainty and variability is implemented in cost data
using Monte Carlo simulations by ﬁrst sampling once from the
uncertainty distributions of the parameters and then sampling
from the variability distributions of the parameters. CONCLU-
SIONS: The different results illustrate the relevance of using
probability distributions for different model parameters, and the
need to separate uncertainty and variability in the EE of health
care programs.
